Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer.

Gomez DR, Byers LA, Nilsson M, Diao L, Wang J, Li L, Tong P, Hofstad M, Saigal B, Wistuba I, Kalhor N, Swisher S, Fan Y, Hong WK, Suraokar M, Behrens C, Moran C, Heymach JV.

Oncotarget. 2018 Jan 30;9(18):14268-14284. doi: 10.18632/oncotarget.24361. eCollection 2018 Mar 6.

2.

MET amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancer.

Fang L, Chen H, Tang Z, Kalhor N, Liu CH, Yao H, Hu S, Lin P, Zhao J, Luthra R, Singh RR, Routbort MJ, Hong D, Medeiros LJ, Lu X.

Oncotarget. 2018 Feb 7;9(16):12959-12970. doi: 10.18632/oncotarget.24430. eCollection 2018 Feb 27.

3.

Immunohistochemical and Image Analysis-based Study Demonstrate that Several Immune Checkpoints are Co-expressed in Non-Small Cell Lung Carcinoma Tumors.

Parra ER, Villalobos P, Zhang J, Behrens C, Mino B, Swisher S, Sepesi B, Weissferdt A, Kalhor N, Heymach JV, Moran C, Zhang J, Lee J, Rodriguez-Canales J, Gibbons D, Wistuba II.

J Thorac Oncol. 2018 Mar 8. pii: S1556-0864(18)30182-5. doi: 10.1016/j.jtho.2018.03.002. [Epub ahead of print]

PMID:
29526824
4.

Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations.

Noll B, Wang WL, Gong Y, Zhao J, Kalhor N, Prieto V, Staerkel G, Roy-Chowdhuri S.

Cancer Cytopathol. 2018 Mar 2. doi: 10.1002/cncy.21987. [Epub ahead of print]

PMID:
29499101
5.

Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer.

Lee WC, Diao L, Wang J, Zhang J, Roarty EB, Varghese S, Chow CW, Fujimoto J, Behrens C, Cascone T, Peng W, Kalhor N, Moran CA, Weissferdt A, Johnson FM, William WN Jr., Swisher SG, Lee JJ, Hong WK, Heymach JV, Wistuba II, Futreal PA, Zhang J.

Mod Pathol. 2018 Feb 6. doi: 10.1038/s41379-018-0029-3. [Epub ahead of print]

PMID:
29410488
6.

Strong spin-photon coupling in silicon.

Samkharadze N, Zheng G, Kalhor N, Brousse D, Sammak A, Mendes UC, Blais A, Scappucci G, Vandersypen LMK.

Science. 2018 Mar 9;359(6380):1123-1127. doi: 10.1126/science.aar4054. Epub 2018 Jan 25.

PMID:
29371427
7.

PRIMARY THYMIC ADENOCARCINOMAS: A clinicopathological and Immunohistochemical study of 16 cases with emphasis on the morphological spectrum of differentiation.

Kalhor N, Moran CA.

Hum Pathol. 2018 Jan 12. pii: S0046-8177(18)30015-7. doi: 10.1016/j.humpath.2018.01.011. [Epub ahead of print]

PMID:
29339175
8.

Pulmonary mucoepidermoid carcinoma: diagnosis and treatment.

Kalhor N, Moran CA.

Expert Rev Respir Med. 2018 Mar;12(3):249-255. doi: 10.1080/17476348.2018.1428563. Epub 2018 Jan 17.

PMID:
29338644
9.

Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer.

Cascone T, Gold KA, Swisher SG, Liu DD, Fossella FV, Sepesi B, Pataer A, Weissferdt A, Kalhor N, Vaporciyan AA, Hofstetter WL, Wistuba II, Heymach JV, Kim ES, William WN Jr..

Ann Thorac Surg. 2018 Feb;105(2):418-424. doi: 10.1016/j.athoracsur.2017.08.052. Epub 2017 Dec 6.

PMID:
29217088
10.

Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer.

Sepesi B, Cuentas EP, Canales JR, Behrens C, Correa AM, Vaporciyan A, Weissferdt A, Kalhor N, Moran C, Swisher S, Wistuba I.

Semin Thorac Cardiovasc Surg. 2017 Autumn;29(3):408-415. doi: 10.1053/j.semtcvs.2017.05.008. Epub 2017 May 26.

PMID:
29195578
11.

Thymoma: a clinicopathological correlation of 1470 cases.

Weissferdt A, Kalhor N, Bishop JA, Jang SJ, Ro J, Petersson F, Wu B, Langman G, Bancroft H, Bi Y, Meng Y, Medeiros F, Brunnstrom H, Spagnolo D, Chai SM, Laycock A, Wakely PE Jr, Elmberger G, Soares FA, Campos AH, Gumurdulu D, Alvarado-Cabrero I, Coppola D, Correa AM, Rice D, Mehran RJ, Sepesi B, Walsh G, Kaiser L, Moran CA.

Hum Pathol. 2018 Mar;73:7-15. doi: 10.1016/j.humpath.2017.08.018. Epub 2017 Aug 26.

PMID:
28851660
12.

Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial.

Khoury JD, Wang WL, Prieto VG, Medeiros LJ, Kalhor N, Hameed M, Broaddus R, Hamilton SR.

Clin Cancer Res. 2018 Feb 1;24(3):521-531. doi: 10.1158/1078-0432.CCR-17-1597. Epub 2017 Aug 24. Review.

PMID:
28839110
13.

JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung Cancer.

Shien K, Papadimitrakopoulou VA, Ruder D, Behrens C, Shen L, Kalhor N, Song J, Lee JJ, Wang J, Tang X, Herbst RS, Toyooka S, Girard L, Minna JD, Kurie JM, Wistuba II, Izzo JG.

Mol Cancer Ther. 2017 Oct;16(10):2234-2245. doi: 10.1158/1535-7163.MCT-17-0148. Epub 2017 Jul 20.

PMID:
28729401
14.

Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients.

Wadhwa R, Wang X, Baladandayuthapani V, Liu B, Shiozaki H, Shimodaira Y, Lin Q, Elimova E, Hofstetter WL, Swisher SG, Rice DC, Maru DM, Kalhor N, Bhutani MS, Weston B, Lee JH, Skinner HD, Scott AW, Kaya DM, Harada K, Berry D, Song S, Ajani JA.

Br J Cancer. 2017 Aug 22;117(5):648-655. doi: 10.1038/bjc.2017.225. Epub 2017 Jul 20.

PMID:
28728163
15.

Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing Radiotherapy.

Adams DL, Adams DK, He J, Kalhor N, Zhang M, Xu T, Gao H, Reuben JM, Qiao Y, Komaki R, Liao Z, Edelman MJ, Tang CM, Lin SH.

Clin Cancer Res. 2017 Oct 1;23(19):5948-5958. doi: 10.1158/1078-0432.CCR-17-0802. Epub 2017 Jul 5.

PMID:
28679765
16.

Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors.

Dalvi MP, Wang L, Zhong R, Kollipara RK, Park H, Bayo J, Yenerall P, Zhou Y, Timmons BC, Rodriguez-Canales J, Behrens C, Mino B, Villalobos P, Parra ER, Suraokar M, Pataer A, Swisher SG, Kalhor N, Bhanu NV, Garcia BA, Heymach JV, Coombes K, Xie Y, Girard L, Gazdar AF, Kittler R, Wistuba II, Minna JD, Martinez ED.

Cell Rep. 2017 May 23;19(8):1669-1684. doi: 10.1016/j.celrep.2017.04.077.

17.

Radiation-induced Angiosarcoma as a Cause of Pleural Effusion.

Miller R, Mudambi L, Vial MR, Kalhor N, Grosu HB.

Am J Respir Crit Care Med. 2017 Aug 15;196(4):e10-e11. doi: 10.1164/rccm.201702-0442IM. No abstract available.

PMID:
28510475
18.

Cutaneous basal cell carcinoma with distant metastasis to thorax and bone : A clinicopathological and immunohistochemical study of 15 cases.

Weissferdt A, Kalhor N, Moran CA.

Virchows Arch. 2017 Jun;470(6):687-694. doi: 10.1007/s00428-017-2121-3. Epub 2017 Apr 8.

PMID:
28391557
19.

Clinicopathologic and genetic features of primary bronchopulmonary mucoepidermoid carcinoma: the MD Anderson Cancer Center experience and comprehensive review of the literature.

Salem A, Bell D, Sepesi B, Papadimitrakopoulou V, El-Naggar A, Moran CA, Kalhor N.

Virchows Arch. 2017 Jun;470(6):619-626. doi: 10.1007/s00428-017-2104-4. Epub 2017 Mar 25. Review.

PMID:
28343305
20.

Expression of PD-1 and PD-L1 in thymic epithelial neoplasms.

Weissferdt A, Fujimoto J, Kalhor N, Rodriguez J, Bassett R, Wistuba II, Moran CA.

Mod Pathol. 2017 Jun;30(6):826-833. doi: 10.1038/modpathol.2017.6. Epub 2017 Mar 10.

PMID:
28281549
21.

Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function.

Choi M, Kadara H, Zhang J, Parra ER, Rodriguez-Canales J, Gaffney SG, Zhao Z, Behrens C, Fujimoto J, Chow C, Kim K, Kalhor N, Moran C, Rimm D, Swisher S, Gibbons DL, Heymach J, Kaftan E, Townsend JP, Lynch TJ, Schlessinger J, Lee J, Lifton RP, Herbst RS, Wistuba II.

Ann Oncol. 2017 Jan 1;28(1):83-89. doi: 10.1093/annonc/mdw437.

PMID:
28177435
22.

"Sarcomatoid" carcinomas of the lung: a clinicopathological study of 86 cases with a new perspective on tumor classification.

Weissferdt A, Kalhor N, Correa AM, Moran CA.

Hum Pathol. 2017 May;63:14-26. doi: 10.1016/j.humpath.2016.12.010. Epub 2016 Dec 16.

PMID:
27993578
23.

Primary Salivary Gland Type Tumors of the Thymus.

Kalhor N, Weissferdt A, Moran CA.

Adv Anat Pathol. 2017 Jan;24(1):15-23. Review.

PMID:
27941539
24.

Pleuromediastinal Epithelial-Myoepithelial Carcinomas: A Clinicopathologic and Immunohistochemical Study of Two Cases.

Weissferdt A, Kalhor N, Moran CA.

Am J Clin Pathol. 2016 Dec;146(6):736-740. doi: 10.1093/ajcp/aqw199. Epub 2016 Nov 17.

PMID:
27864182
25.
26.

Ectopic Hamartomatous Thymoma-New Insights Into a Challenging Entity: A Clinicopathologic and Immunohistochemical Study of 9 Cases.

Weissferdt A, Kalhor N, Petersson F, Moran CA.

Am J Surg Pathol. 2016 Nov;40(11):1571-1576.

PMID:
27428736
27.

Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer.

Wang J, Kalhor N, Hu J, Wang B, Chu H, Zhang B, Guan Y, Wu Y.

PLoS One. 2016 Oct 3;11(10):e0163397. doi: 10.1371/journal.pone.0163397. eCollection 2016.

28.

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.

Kadara H, Choi M, Zhang J, Parra ER, Rodriguez-Canales J, Gaffney SG, Zhao Z, Behrens C, Fujimoto J, Chow C, Yoo Y, Kalhor N, Moran C, Rimm D, Swisher S, Gibbons DL, Heymach J, Kaftan E, Townsend JP, Lynch TJ, Schlessinger J, Lee J, Lifton RP, Wistuba II, Herbst RS.

Ann Oncol. 2017 Jan 1;28(1):75-82. doi: 10.1093/annonc/mdw436.

PMID:
27687306
29.

Primary Mediastinal Yolk Sac Tumors: An Immunohistochemical Analysis of 14 Cases.

Weissferdt A, Kalhor N, Rodriguez Canales J, Fujimoto J, Wistuba II, Moran CA.

Appl Immunohistochem Mol Morphol. 2016 Sep 16. [Epub ahead of print]

PMID:
27643524
30.

Spindle cell and pleomorphic ("sarcomatoid") carcinomas of the lung: an immunohistochemical analysis of 86 cases.

Weissferdt A, Kalhor N, Rodriguez Canales J, Fujimoto J, Wistuba II, Moran CA.

Hum Pathol. 2017 Jan;59:1-9. doi: 10.1016/j.humpath.2016.08.003. Epub 2016 Aug 25.

PMID:
27569293
31.

The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer.

Papadimitrakopoulou V, Lee JJ, Wistuba II, Tsao AS, Fossella FV, Kalhor N, Gupta S, Byers LA, Izzo JG, Gettinger SN, Goldberg SB, Tang X, Miller VA, Skoulidis F, Gibbons DL, Shen L, Wei C, Diao L, Peng SA, Wang J, Tam AL, Coombes KR, Koo JS, Mauro DJ, Rubin EH, Heymach JV, Hong WK, Herbst RS.

J Clin Oncol. 2016 Aug 1. pii: JCO660084. [Epub ahead of print]

32.

Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis.

Padanad MS, Konstantinidou G, Venkateswaran N, Melegari M, Rindhe S, Mitsche M, Yang C, Batten K, Huffman KE, Liu J, Tang X, Rodriguez-Canales J, Kalhor N, Shay JW, Minna JD, McDonald J, Wistuba II, DeBerardinis RJ, Scaglioni PP.

Cell Rep. 2016 Aug 9;16(6):1614-1628. doi: 10.1016/j.celrep.2016.07.009. Epub 2016 Jul 28.

33.

Sebaceous lymphadenoma of the thymus: A clinicopathologic and immunohistochemical study of 2 cases.

Weissferdt A, Kalhor N, Moran CA.

Hum Pathol. 2016 Oct;56:189-93. doi: 10.1016/j.humpath.2016.06.015. Epub 2016 Jun 29.

PMID:
27374279
34.

Thymomas With Extensive Clear Cell Component:  A Clinicopathologic and Immunohistochemical Study of Nine Cases.

Weissferdt A, Kalhor N, Moran CA.

Am J Clin Pathol. 2016 Jul;146(1):132-6. doi: 10.1093/ajcp/aqw094. Epub 2016 Jun 30.

PMID:
27371363
35.

Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients.

Parra ER, Behrens C, Rodriguez-Canales J, Lin H, Mino B, Blando J, Zhang J, Gibbons DL, Heymach JV, Sepesi B, Swisher SG, Weissferdt A, Kalhor N, Izzo J, Kadara H, Moran C, Lee JJ, Wistuba II.

Clin Cancer Res. 2016 Dec 15;22(24):6278-6289. Epub 2016 Jun 1.

36.

Genomic Landscape Established by Allelic Imbalance in the Cancerization Field of a Normal Appearing Airway.

Jakubek Y, Lang W, Vattathil S, Garcia M, Xu L, Huang L, Yoo SY, Shen L, Lu W, Chow CW, Weber Z, Davies G, Huang J, Behrens C, Kalhor N, Moran C, Fujimoto J, Mehran R, El-Zein R, Swisher SG, Wang J, Fowler J, Spira AE, Ehli EA, Wistuba II, Scheet P, Kadara H.

Cancer Res. 2016 Jul 1;76(13):3676-83. doi: 10.1158/0008-5472.CAN-15-3064. Epub 2016 May 23.

37.

Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers.

Zhang YA, Ma X, Sathe A, Fujimoto J, Wistuba I, Lam S, Yatabe Y, Wang YW, Stastny V, Gao B, Larsen JE, Girard L, Liu X, Song K, Behrens C, Kalhor N, Xie Y, Zhang MQ, Minna JD, Gazdar AF.

J Thorac Oncol. 2016 Mar;11(3):346-360. doi: 10.1016/j.jtho.2015.11.004. Epub 2015 Dec 25.

38.

Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations.

Riquelme E, Behrens C, Lin HY, Simon G, Papadimitrakopoulou V, Izzo J, Moran C, Kalhor N, Lee JJ, Minna JD, Wistuba II.

Cancer Res. 2016 Feb 1;76(3):675-85. doi: 10.1158/0008-5472.CAN-15-1141. Epub 2015 Dec 16.

39.

Primary Pulmonary Salivary Gland-type Tumors: A Review and Update.

Falk N, Weissferdt A, Kalhor N, Moran CA.

Adv Anat Pathol. 2016 Jan;23(1):13-23. doi: 10.1097/PAP.0000000000000099. Review.

PMID:
26645458
40.

De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated With Poor Prognosis.

Liu W, Hu S, Konopleva M, Khoury JD, Kalhor N, Tang G, Bueso-Ramos CE, Jorgensen JL, Lin P, Medeiros LJ, Lu X.

Pediatr Hematol Oncol. 2015;32(8):535-47. doi: 10.3109/08880018.2015.1087611. Epub 2015 Nov 11.

PMID:
26558423
41.

Evaluation of the ability of natural and synthetic scaffolds in providing an appropriate environment for growth and chondrogenic differentiation of adipose-derived mesenchymal stem cells.

Sheykhhasan M, Qomi RT, Kalhor N, Mehdizadeh M, Ghiasi M.

Indian J Orthop. 2015 Sep-Oct;49(5):561-8. doi: 10.4103/0019-5413.164043.

42.

Primary Pulmonary Lymphomas.

Piña-Oviedo S, Weissferdt A, Kalhor N, Moran CA.

Adv Anat Pathol. 2015 Nov;22(6):355-75. doi: 10.1097/PAP.0000000000000090. Review.

PMID:
26452211
43.

Primary thymic cholesteroloma: a clinicopathological correlation of four cases of an unusual benign lesion.

Weissferdt A, Kalhor N, Moran C.

Virchows Arch. 2015 Nov;467(5):609-11. doi: 10.1007/s00428-015-1822-8. Epub 2015 Aug 13.

PMID:
26266777
44.

Cystic well-differentiated squamous cell carcinoma of the thymus: a clinicopathological and immunohistochemical study of six cases.

Weissferdt A, Kalhor N, Moran CA.

Histopathology. 2016 Feb;68(3):333-8. doi: 10.1111/his.12748. Epub 2015 Jul 14.

PMID:
26031186
45.

Assessing the prevalence of bacterial vaginosis among infertile women of Qom city.

Ghiasi M, Fazaeli H, Kalhor N, Sheykh-Hasan M, Tabatabaei-Qomi R.

Iran J Microbiol. 2014 Dec;6(6):404-8.

46.

Ewing sarcoma with extensive neural differentiation: a clinicopathologic, immunohistochemical, and molecular analysis of three cases.

Weissferdt A, Kalhor N, Moran CA.

Am J Clin Pathol. 2015 May;143(5):659-64. doi: 10.1309/AJCPFHFX07JFCRGU.

PMID:
25873499
47.

Development of a PCR assay to detect mycoplasma contamination in cord blood hematopoietic stem cells.

Tabatabaei-Qomi R, Sheykh-Hasan M, Fazaely H, Kalhor N, Ghiasi M.

Iran J Microbiol. 2014 Aug;6(4):281-4.

48.

RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer.

Guo C, Hao C, Shao R, Fang B, Correa AM, Hofstetter WL, Roth JA, Behrens C, Kalhor N, Wistuba II, Swisher SG, Pataer A.

Oncotarget. 2015 May 10;6(13):11114-24.

49.

An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung.

Zenali MJ, Weissferdt A, Solis LM, Ali S, Tang X, Mehran RJ, Wistuba II, Moran CA, Kalhor N.

Hum Pathol. 2015 Jun;46(6):836-42. doi: 10.1016/j.humpath.2014.10.032. Epub 2015 Feb 20.

PMID:
25776025
50.

The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer.

Song S, Honjo S, Jin J, Chang SS, Scott AW, Chen Q, Kalhor N, Correa AM, Hofstetter WL, Albarracin CT, Wu TT, Johnson RL, Hung MC, Ajani JA.

Clin Cancer Res. 2015 Jun 1;21(11):2580-90. doi: 10.1158/1078-0432.CCR-14-2191. Epub 2015 Mar 4.

Supplemental Content

Loading ...
Support Center